UL Solutions Short Interest Climbs to a Year High Before Q3 Results
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short sellers have built their largest position in UL Solutions in at least a year, with 8.9% of the free float now borrowed against the stock ahead of Monday's Q3 earnings release. That figure has risen 29% over the past month, with the bulk of the move concentrated in October as shares recovered from their August lows.
The week before results tells a split story. The stock gained 1.8% to close at $74.76, outperforming the median of its closest peers, which fell roughly 1.6% over the same period. Yet short interest continued to inch higher, adding a further 1% on the week. Borrow costs remain low at 0.50%, down 10% over the past seven days, and availability is generous at 499%, meaning roughly five shares remain available for every one already lent out. The lending market is not under pressure. What is rising is the number of investors choosing to take a short position, not the cost of doing so.
The analyst community sits well above the current share price. The consensus mean target is $96.57, implying significant upside from $74.76, though all meaningful analyst moves date to August or earlier. After the company fell 13% on the day of its Q2 report in early August, UBS, Citigroup, and Wells Fargo all trimmed targets sharply, with UBS cutting from $110 to $96 and Citi from $106 to $83. UBS subsequently edged its target back up to $97 in October. The bear case centres on regulatory risk, any loosening of certification requirements would directly reduce demand for the testing and inspection work that drives UL Solutions' revenue. Bulls point to the company's brand strength and diversified service lines, though its roughly 24% revenue exposure to China remains a risk factor that the Street has not fully resolved.
The one sharp data point outside the financials is retail attention. Wikipedia and ORTEX page-view data show the company is drawing substantially more retail interest than at any point in the prior 90 days, with a z-score of 3.96 as of October 22. That spike in attention coincides with the stock's 15% monthly price gain and the approaching earnings date. Separately, CEO Jennifer Scanlon has been a steady seller, offloading 25,000 shares over the past 90 days for just under $1.8 million, all under a pre-arranged 10b5-1 plan, which limits the signal value of those transactions.
The print will test whether the Q2 miss was an isolated stumble or the start of a more persistent slowdown in the testing and certification cycle, particularly given the scale of the short position built since that report.
Stocks in this article
See the live data behind this article on ORTEX.
Open ULS on ORTEX →How this article was generated
- Generated
- 31 Oct 2026, 04:28
- Data as of
- 31 Oct 2026, 04:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.